查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2058973

穿戴式醫療設備市場預測至2034年—按產品類型、裝置類型、連接方式、銷售管道、應用、最終用戶和地區分類的全球分析

Wearable Healthcare Devices Market Forecasts to 2034 - Global Analysis By Product Type, Device Type, Connectivity, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球穿戴式醫療設備市場規模將達到 321 億美元，到 2034 年將達到 984 億美元，預測期內複合年成長率為 15.0%。

穿戴式醫療設備是指佩戴在身上或貼附於皮膚上的電子設備，用於持續或定期監測生理參數、藥物使用和健康指標。這些設備包括智慧型手錶、健身追蹤器、連續血糖監測儀、穿戴式心電圖監測儀、智慧型貼片和脈動式血氧監測儀系統，它們收集生物特徵數據並將其傳輸到連接的平台，用於臨床分析和用戶健康追蹤。透過實現遠端患者監護、慢性病管理和預防性健康管理，穿戴式醫療設備正在將醫療服務模式從零散的諮詢轉變為持續的、數據驅動的健康管理。

遠端患者監護和慢性病管理解決方案的快速普及

在全球範圍內，糖尿病、心血管疾病和呼吸系統疾病等慢性病的日益增多，推動了在傳統臨床環境之外進行持續生理監測的需求。穿戴式醫療設備使臨床醫生能夠即時追蹤患者的生命徵象，及早發現病情惡化趨勢，並採取積極措施，從而可能減少住院和急診就診次數。多個市場正在製定遠端監測服務的報銷機制，提高了穿戴式裝置大規模部署的經濟可行性。此外，全球人口老化也持續推動了對居家監測解決方案的需求，以支持老年人在家中獨立生活，從而為穿戴式醫療設備建立了一個穩健且不斷成長的市場基礎。

資料隱私問題和互通性限制制約了其在臨床環境中的應用。

穿戴式醫療設備持續產生高度敏感的生物特徵數據，引發患者和監管機構對隱私問題的嚴重擔憂。關於資料所有權、科技公司2次利用以及消費級設備加密的合理性等問題，正在削弱臨床應用的積極性，並阻礙其在正規醫療機構的大規模普及。同時，缺乏標準化的數據格式和整合協議限制了穿戴式設備數據與電子健康記錄系統的無縫整合，降低了其臨床效用。在建立並實施大規模的互通性標準和透明的資料管治框架之前，這些障礙將繼續限制那些規避風險的醫療機構採用穿戴式醫療設備。

先進生物感測器的整合實現了對複雜生物標記的非侵入性監測。

微型化和生物感測器技術的進步使得穿戴式裝置能夠以非侵入式的方式測量日益複雜的健康指標，例如連續血糖值、乳酸、皮質醇和電解質濃度。這些功能曾經僅限於檢查室和臨床環境，如今正透過新一代智慧型貼片和智慧型手錶。對於糖尿病、心血管疾病和代謝失調患者而言，非侵入式監測顯著提升了疾病管理的便利性和依從性。成功將經過檢驗和監管部門核准的非侵入式生物感測器推向市場的製造商，將為穿戴式醫療生態系統開拓新的患者群體和收入來源。

全球市場的監管差異和臨床檢驗要求

穿戴式醫療設備面臨監管環境分散的困境。美國、歐盟和亞洲市場對臨床檢驗、安全認證和市場核准的要求差異顯著。隨著設備功能從健康追蹤擴展到醫療監測，監管審查也變得更加嚴格，需要提供大量的臨床試驗證據。這些監管流程耗時漫長、成本高昂，且核准結果充滿不確定性。對於希望提供全球檢驗的醫療監測功能的製造商而言，應對複雜多變的法規結構需要投入大量資源，並構成重大障礙，尤其對於小規模的創新者和參與企業。

新冠疫情的感染疾病：

新冠疫情大大提升了消費者和臨床對穿戴式醫療設備的興趣，遠距健康監測既成為公共衛生必需，也成為消費者安全的第一要務。隨著人們希望在家中監測血氧飽和度，脈搏血氧飽和度分析儀的需求激增。遠端醫療的擴展為穿戴式裝置數據在虛擬醫療平台中的整合開闢了新的途徑。疫情也凸顯了臨床相關人員對持續遠端監測的需求，促使醫療系統投資於疫情後臨床級穿戴裝置計畫。這種危機帶來的實際效果為穿戴式醫療設備市場提供了持續的動力，顯著推動了其成長。

在預測期內，智慧型手錶細分市場預計將佔據最大的市場佔有率。

由於智慧手錶擁有廣泛的消費者群體，且其臨床實用監測功能不斷擴展，預計在預測期內，智慧型手錶細分市場將佔據最大的市場佔有率。領先的科技品牌正逐步在智慧型手錶平台中添加心電圖監測、心律不整通知、血氧飽和度測量和跌倒偵測等醫療級功能，模糊了家用電子電器和醫療設備之間的界線。旗艦智慧型手錶平台的大規模部署、強大的品牌忠誠度以及持續的功能擴展預計將確保其持續盈利。臨床級監測功能的法規核准進一步鞏固了智慧型手錶作為核心醫療穿戴裝置類別的地位。

預計在預測期內，遠距病患監測（RPM）細分市場將呈現最高的複合年成長率。

在預測期內，遠端患者監護（RPM）領域預計將呈現最高的成長率，這主要得益於醫療保健系統向以價值為導向的醫療模式的策略轉變，該模式優先考慮主動式門診管理。能夠將生命徵象和疾病生物標記持續傳輸至臨床平台的穿戴式設備，正成為管理心臟衰竭、慢性阻塞性肺病和糖尿病等高風險患者族群的重要工具。在包括美國和歐洲主要國家在內的關鍵市場，RPM服務的保險覆蓋範圍不斷擴大，降低了大規模臨床應用的經濟門檻，使其成為穿戴式醫療設備在監護應用領域強勁的成長引擎。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於消費者較高的健康意識、完善的數位健康基礎設施以及遠端患者監護服務有利的報銷政策。美國是最大的單一國家市場，背後是消費技術和醫療設備公司組成的生態系統，這些公司是推動持續創新的領導者。除了強勁的消費者購買力外，穿戴式裝置數據與遠端醫療平台和健康管理專案的深度整合也支撐著企業層面的強勁需求。政府為促進預防醫學和慢性病管理的措施將在整個預測期進一步鞏固該地區的市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這反映了中國、印度和東南亞中產階級健康意識的增強、智慧型手機的普及以及電子商務分銷管道的擴張。當地消費電子巨頭正在推出價格極具競爭力的穿戴式健康監測設備，以滿足區域消費者的偏好。中國和印度政府的數位健康計畫正在將穿戴式監測技術納入國家健康管理策略。年輕一代和精通技術的消費者對這些設備的快速接受度正在形成良性循環，預計全部區域將繼續保持強勁的兩位數成長率。

主要公司：

穿戴式醫療設備市場的主要參與者包括蘋果、三星電子有限公司、雅培實驗室、德康醫療公司、美敦力公司、皇家飛利浦公司、佳明有限公司、歐姆龍公司、谷歌有限責任公司、華為技術有限公司、小米公司、Masimo公司、瑞思邁公司、Withings SA和iRhythm Technologies公司。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球穿戴式醫療設備市場：依產品類型分類

  • 智慧型手錶
  • 健身活動追蹤器
  • 智慧型貼片
  • 神經監測設備
  • 持續血糖監測（CGM）設備
  • 穿戴式心電圖監測器
  • 脈搏血氧飽和度分析儀
  • 助聽器
  • 穿戴式血壓監測器
  • 穿戴式呼吸監測設備

第6章 全球穿戴式醫療設備市場：依設備類型分類

  • 診斷和監測設備
    • 生命徵象監測設備
    • 睡眠監測設備
    • 心電圖和心臟監測設備
    • 神經監測設備
    • 血糖值監測設備
  • 治療設備
    • 疼痛管理設備
    • 胰島素輸注裝置
    • 呼吸治療設備
    • 復健設備

第7章 全球穿戴式醫療設備市場：連結性

  • Bluetooth
  • Wi-Fi
  • NFC
  • 蜂巢式網路
  • 支援物聯網的連接

第8章 全球穿戴式醫療設備市場：按分銷管道分類

  • 線上管道
  • 藥局
  • 專賣店
  • 大型超市和零售店
  • 直銷

第9章 全球穿戴式醫療設備市場：按應用領域分類

  • 健身與健康
  • 慢性病管理
    • 糖尿病管理
    • 心血管疾病監測
    • 呼吸系統疾病監測
    • 神經系統疾病監測
  • 遠端患者監護（RPM）
  • 家庭醫療保健
  • 運動與健身監測
  • 復健與恢復
  • 老年護理監測

第10章 全球穿戴式醫療設備市場：依最終用戶分類

  • 個人消費者
  • 醫院和診所
  • 門診部
  • 居家醫療
  • 運動健身中心

第11章 全球穿戴式醫療設備市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Apple Inc.
  • Samsung Electronics Co., Ltd.
  • Abbott Laboratories
  • DexCom, Inc.
  • Medtronic plc
  • Koninklijke Philips NV
  • Garmin Ltd.
  • OMRON Corporation
  • Google LLC
  • Huawei Technologies Co., Ltd.
  • Xiaomi Corporation
  • Masimo Corporation
  • ResMed Inc.
  • Withings SA
  • iRhythm Technologies, Inc.
Product Code: SMRC36602

According to Stratistics MRC, the Global Wearable Healthcare Devices Market is accounted for $32.1 billion in 2026 and is expected to reach $98.4 billion by 2034, growing at a CAGR of 15.0% during the forecast period. Wearable Healthcare Devices are body-worn or skin-adhered electronic instruments that continuously or periodically monitor physiological parameters, therapeutic delivery, and wellness indicators. Encompassing smartwatches, fitness trackers, continuous glucose monitors, wearable ECG monitors, smart patches, and pulse oximeters, these devices collect biometric data and transmit it to connected platforms for clinical analysis or consumer wellness tracking. By enabling remote patient monitoring, chronic disease management, and proactive health engagement, wearable healthcare devices are transforming care delivery from episodic clinical encounters to continuous, data-driven health oversight.

Market Dynamics:

Driver:

Surging adoption of remote patient monitoring and chronic disease management solutions

The global burden of chronic diseases including diabetes, cardiovascular disorders, and respiratory conditions is propelling demand for continuous physiological monitoring outside traditional clinical settings. Wearable healthcare devices enable clinicians to track patient vitals in real time, identify deteriorating trends early, and intervene proactively reducing hospitalizations and emergency visits. Reimbursement frameworks in several markets are increasingly accommodating remote monitoring services, improving the economic viability of wearable deployment at scale. Additionally, aging populations worldwide are generating sustained demand for home-based monitoring solutions that support aging in place, giving wearable healthcare devices an expanding and durable market foundation.

Restraint:

Data privacy concerns and interoperability limitations constraining clinical adoption

Wearable healthcare devices generate continuous streams of sensitive biometric data, raising significant privacy concerns among patients and regulatory bodies. Questions about data ownership, secondary use by technology companies, and the adequacy of encryption in consumer-grade devices temper clinical enthusiasm and inhibit large-scale deployment in formal healthcare settings. Simultaneously, a lack of standardized data formats and integration protocols limits the ability of wearable device data to flow seamlessly into electronic health record systems, reducing clinical utility. Until comprehensive interoperability standards and transparent data governance frameworks are established and enforced, these barriers will continue to constrain adoption among risk-averse healthcare providers.

Opportunity:

Integration of advanced biosensors enabling non-invasive monitoring of complex biomarkers

Technological advances in miniaturized biosensor technology are enabling wearable devices to measure increasingly complex health indicators non-invasively, including continuous blood glucose levels, lactate, cortisol, and electrolyte concentrations. These capabilities, once confined to laboratory or clinical settings, are now becoming accessible through next-generation smart patches and next-gen smartwatches. For patients with diabetes, cardiovascular conditions, and metabolic disorders, non-invasive monitoring represents a transformative improvement in disease management convenience and compliance. Manufacturers who successfully bring validated, regulatory-cleared non-invasive biosensors to market will unlock substantial new patient populations and revenue streams within the wearable healthcare ecosystem.

Threat:

Regulatory variability and clinical validation requirements across global markets

Wearable healthcare devices face a fragmented regulatory landscape, with requirements for clinical validation, safety certification, and market authorization varying significantly across the United States, European Union, and Asian markets. Devices crossing the boundary from wellness tracking to medical monitoring face substantially heightened regulatory scrutiny, requiring extensive clinical trial evidence. These regulatory pathways are lengthy, costly, and carry uncertainty regarding approval outcomes. For manufacturers seeking to offer medically validated monitoring capabilities globally, navigating divergent and evolving regulatory frameworks imposes significant resource demands, creating a barrier that particularly disadvantages smaller innovators and emerging-market entrants.

Covid-19 Impact:

The COVID-19 pandemic dramatically accelerated consumer and clinical interest in wearable healthcare devices as remote health monitoring became both a public health imperative and a consumer safety priority. Demand for pulse oximeters surged as individuals sought to monitor oxygen saturation levels at home. Telehealth expansion created new integration pathways for wearable data within virtual care platforms. The pandemic also validated the case for continuous remote monitoring among clinical stakeholders, driving post-pandemic investment in clinical-grade wearable programs by health systems. This crisis-induced validation created durable momentum that has significantly elevated the growth trajectory of the wearable healthcare device market.

The Smartwatches segment is expected to be the largest during the forecast period

The Smartwatches segment is expected to account for the largest market share during the forecast period, combining broad consumer appeal with an expanding suite of clinically relevant monitoring capabilities. Leading technology brands have progressively added medical-grade features including ECG monitoring, irregular rhythm notifications, blood oxygen measurement, and fall detection to their smartwatch platforms, blurring the boundary between consumer electronics and healthcare devices. The large installed base, strong brand loyalty, and continuous feature expansion of flagship smartwatch platforms ensure sustained revenue leadership. Regulatory clearances for clinical-grade monitoring features are further strengthening the position of smartwatches as a cornerstone healthcare wearable category.

The Remote Patient Monitoring (RPM) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Remote Patient Monitoring (RPM) segment is predicted to witness the highest growth rate, driven by healthcare systems' strategic shift toward value-based care models that prioritize proactive outpatient management. Wearable devices enabling continuous vital sign and disease biomarker transmission to clinical platforms are becoming integral tools for managing high-risk patient populations with heart failure, COPD, and diabetes. Expanding reimbursement coverage for RPM services in major markets including the United States and key European economies is reducing the economic barrier to large-scale clinical deployment, creating a powerful growth engine for wearable healthcare devices in the monitoring application domain.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, owing to high consumer health awareness, robust digital health infrastructure, and favorable reimbursement conditions for remote patient monitoring services. The United States represents the largest single national market, supported by an ecosystem of leading consumer technology and medical device companies driving continuous innovation. Strong clinical integration of wearable data into telehealth platforms and health management programs sustains enterprise-level demand alongside robust consumer purchasing. Government initiatives promoting preventive care and chronic disease management further underpin the region's dominant market position throughout the forecast horizon.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, reflecting burgeoning middle-class health consciousness, smartphone penetration, and expanding e-commerce distribution channels across China, India, and Southeast Asia. Local consumer electronics giants are introducing competitively priced health-monitoring wearables tailored to regional consumer preferences. Government digital health programs in China and India are incorporating wearable monitoring into national health management strategies. Rapid adoption among younger, technology-forward demographics is creating a self-reinforcing growth cycle that is expected to sustain strong double-digit expansion rates across the region.

Key Players:

Some of the key players in the Wearable Healthcare Devices Market include Apple Inc., Samsung Electronics Co., Ltd., Abbott Laboratories, DexCom, Inc., Medtronic plc, Koninklijke Philips N.V., Garmin Ltd., OMRON Corporation, Google LLC, Huawei Technologies Co., Ltd., Xiaomi Corporation, Masimo Corporation, ResMed Inc., Withings SA, and iRhythm Technologies, Inc.

Key Developments:

In February 2026, Apple Inc. received FDA clearance for a new non-invasive blood glucose monitoring feature integrated into its latest Apple Watch, marking a significant technological milestone that enables continuous glucose tracking for diabetic patients without finger-prick calibration, potentially transforming diabetes management and substantially expanding the clinical utility of consumer smartwatches.

In January 2026, DexCom, Inc. announced the commercial launch of its Stelo biosensor patch in additional international markets, delivering over-the-counter continuous glucose monitoring access to pre-diabetic and type 2 diabetic individuals who do not require insulin therapy, thereby broadening its addressable market and reinforcing its leadership in the consumer glucose monitoring segment.

Product Types Covered:

  • Smartwatches
  • Fitness & Activity Trackers
  • Smart Patches
  • Neuro-monitoring Devices
  • Continuous Glucose Monitoring (CGM) Devices
  • Wearable ECG Monitors
  • Pulse Oximeters
  • Hearing Aids
  • Wearable Blood Pressure Monitors
  • Wearable Respiratory Monitoring Devices

Device Types Covered:

  • Diagnostic & Monitoring Devices
  • Therapeutic Devices

Connectivities Covered:

  • Bluetooth
  • Wi-Fi
  • NFC
  • Cellular Networks
  • IoT-enabled Connectivity

Distribution Channels Covered:

  • Online Channels
  • Pharmacies
  • Specialty Stores
  • Hypermarkets & Retail Stores
  • Direct Sales

Applications Covered:

  • Fitness & Wellness
  • Chronic Disease Management
  • Remote Patient Monitoring (RPM)
  • Home Healthcare
  • Sports & Fitness Monitoring
  • Rehabilitation & Recovery
  • Elderly Care Monitoring

End Users Covered:

  • Individual Consumers
  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Homecare Settings
  • Sports & Fitness Centers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 3032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Wearable Healthcare Devices Market, By Product Type

  • 5.1 Smartwatches
  • 5.2 Fitness & Activity Trackers
  • 5.3 Smart Patches
  • 5.4 Neuro-monitoring Devices
  • 5.5 Continuous Glucose Monitoring (CGM) Devices
  • 5.6 Wearable ECG Monitors
  • 5.7 Pulse Oximeters
  • 5.8 Hearing Aids
  • 5.9 Wearable Blood Pressure Monitors
  • 5.10 Wearable Respiratory Monitoring Devices

6 Global Wearable Healthcare Devices Market, By Device Type

  • 6.1 Diagnostic & Monitoring Devices
    • 6.1.1 Vital Sign Monitoring Devices
    • 6.1.2 Sleep Monitoring Devices
    • 6.1.3 ECG & Cardiac Monitoring Devices
    • 6.1.4 Neuromonitoring Devices
    • 6.1.5 Glucose Monitoring Devices
  • 6.2 Therapeutic Devices
    • 6.2.1 Pain Management Devices
    • 6.2.2 Insulin Delivery Devices
    • 6.2.3 Respiratory Therapy Devices
    • 6.2.4 Rehabilitation Devices

7 Global Wearable Healthcare Devices Market, By Connectivity

  • 7.1 Bluetooth
  • 7.2 Wi-Fi
  • 7.3 NFC
  • 7.4 Cellular Networks
  • 7.5 IoT-enabled Connectivity

8 Global Wearable Healthcare Devices Market, By Distribution Channel

  • 8.1 Online Channels
  • 8.2 Pharmacies
  • 8.3 Specialty Stores
  • 8.4 Hypermarkets & Retail Stores
  • 8.5 Direct Sales

9 Global Wearable Healthcare Devices Market, By Application

  • 9.1 Fitness & Wellness
  • 9.2 Chronic Disease Management
    • 9.2.1 Diabetes Management
    • 9.2.2 Cardiovascular Disease Monitoring
    • 9.2.3 Respiratory Disorder Monitoring
    • 9.2.4 Neurological Disorder Monitoring
  • 9.3 Remote Patient Monitoring (RPM)
  • 9.4 Home Healthcare
  • 9.5 Sports & Fitness Monitoring
  • 9.6 Rehabilitation & Recovery
  • 9.7 Elderly Care Monitoring

10 Global Wearable Healthcare Devices Market, By End User

  • 10.1 Individual Consumers
  • 10.2 Hospitals & Clinics
  • 10.3 Ambulatory Care Centers
  • 10.4 Homecare Settings
  • 10.5 Sports & Fitness Centers

11 Global Wearable Healthcare Devices Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Apple Inc.
  • 14.2 Samsung Electronics Co., Ltd.
  • 14.3 Abbott Laboratories
  • 14.4 DexCom, Inc.
  • 14.5 Medtronic plc
  • 14.6 Koninklijke Philips N.V.
  • 14.7 Garmin Ltd.
  • 14.8 OMRON Corporation
  • 14.9 Google LLC
  • 14.10 Huawei Technologies Co., Ltd.
  • 14.11 Xiaomi Corporation
  • 14.12 Masimo Corporation
  • 14.13 ResMed Inc.
  • 14.14 Withings SA
  • 14.15 iRhythm Technologies, Inc.

List of Tables

  • Table 1 Global Wearable Healthcare Devices Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Wearable Healthcare Devices Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Wearable Healthcare Devices Market Outlook, By Smartwatches (2023-2034) ($MN)
  • Table 4 Global Wearable Healthcare Devices Market Outlook, By Fitness & Activity Trackers (2023-2034) ($MN)
  • Table 5 Global Wearable Healthcare Devices Market Outlook, By Smart Patches (2023-2034) ($MN)
  • Table 6 Global Wearable Healthcare Devices Market Outlook, By Neuro-monitoring Devices (2023-2034) ($MN)
  • Table 7 Global Wearable Healthcare Devices Market Outlook, By Continuous Glucose Monitoring (CGM) Devices (2023-2034) ($MN)
  • Table 8 Global Wearable Healthcare Devices Market Outlook, By Wearable ECG Monitors (2023-2034) ($MN)
  • Table 9 Global Wearable Healthcare Devices Market Outlook, By Pulse Oximeters (2023-2034) ($MN)
  • Table 10 Global Wearable Healthcare Devices Market Outlook, By Hearing Aids (2023-2034) ($MN)
  • Table 11 Global Wearable Healthcare Devices Market Outlook, By Wearable Blood Pressure Monitors (2023-2034) ($MN)
  • Table 12 Global Wearable Healthcare Devices Market Outlook, By Wearable Respiratory Monitoring Devices (2023-2034) ($MN)
  • Table 13 Global Wearable Healthcare Devices Market Outlook, By Device Type (2023-2034) ($MN)
  • Table 14 Global Wearable Healthcare Devices Market Outlook, By Diagnostic & Monitoring Devices (2023-2034) ($MN)
  • Table 15 Global Wearable Healthcare Devices Market Outlook, By Vital Sign Monitoring Devices (2023-2034) ($MN)
  • Table 16 Global Wearable Healthcare Devices Market Outlook, By Sleep Monitoring Devices (2023-2034) ($MN)
  • Table 17 Global Wearable Healthcare Devices Market Outlook, By ECG & Cardiac Monitoring Devices (2023-2034) ($MN)
  • Table 18 Global Wearable Healthcare Devices Market Outlook, By Neuromonitoring Devices (2023-2034) ($MN)
  • Table 19 Global Wearable Healthcare Devices Market Outlook, By Glucose Monitoring Devices (2023-2034) ($MN)
  • Table 20 Global Wearable Healthcare Devices Market Outlook, By Therapeutic Devices (2023-2034) ($MN)
  • Table 21 Global Wearable Healthcare Devices Market Outlook, By Pain Management Devices (2023-2034) ($MN)
  • Table 22 Global Wearable Healthcare Devices Market Outlook, By Insulin Delivery Devices (2023-2034) ($MN)
  • Table 23 Global Wearable Healthcare Devices Market Outlook, By Respiratory Therapy Devices (2023-2034) ($MN)
  • Table 24 Global Wearable Healthcare Devices Market Outlook, By Rehabilitation Devices (2023-2034) ($MN)
  • Table 25 Global Wearable Healthcare Devices Market Outlook, By Connectivity (2023-2034) ($MN)
  • Table 26 Global Wearable Healthcare Devices Market Outlook, By Bluetooth (2023-2034) ($MN)
  • Table 27 Global Wearable Healthcare Devices Market Outlook, By Wi-Fi (2023-2034) ($MN)
  • Table 28 Global Wearable Healthcare Devices Market Outlook, By NFC (2023-2034) ($MN)
  • Table 29 Global Wearable Healthcare Devices Market Outlook, By Cellular Networks (2023-2034) ($MN)
  • Table 30 Global Wearable Healthcare Devices Market Outlook, By IoT-enabled Connectivity (2023-2034) ($MN)
  • Table 31 Global Wearable Healthcare Devices Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 32 Global Wearable Healthcare Devices Market Outlook, By Online Channels (2023-2034) ($MN)
  • Table 33 Global Wearable Healthcare Devices Market Outlook, By Pharmacies (2023-2034) ($MN)
  • Table 34 Global Wearable Healthcare Devices Market Outlook, By Specialty Stores (2023-2034) ($MN)
  • Table 35 Global Wearable Healthcare Devices Market Outlook, By Hypermarkets & Retail Stores (2023-2034) ($MN)
  • Table 36 Global Wearable Healthcare Devices Market Outlook, By Direct Sales (2023-2034) ($MN)
  • Table 37 Global Wearable Healthcare Devices Market Outlook, By Application (2023-2034) ($MN)
  • Table 38 Global Wearable Healthcare Devices Market Outlook, By Fitness & Wellness (2023-2034) ($MN)
  • Table 39 Global Wearable Healthcare Devices Market Outlook, By Chronic Disease Management (2023-2034) ($MN)
  • Table 40 Global Wearable Healthcare Devices Market Outlook, By Diabetes Management (2023-2034) ($MN)
  • Table 41 Global Wearable Healthcare Devices Market Outlook, By Cardiovascular Disease Monitoring (2023-2034) ($MN)
  • Table 42 Global Wearable Healthcare Devices Market Outlook, By Respiratory Disorder Monitoring (2023-2034) ($MN)
  • Table 43 Global Wearable Healthcare Devices Market Outlook, By Neurological Disorder Monitoring (2023-2034) ($MN)
  • Table 44 Global Wearable Healthcare Devices Market Outlook, By Remote Patient Monitoring (RPM) (2023-2034) ($MN)
  • Table 45 Global Wearable Healthcare Devices Market Outlook, By Home Healthcare (2023-2034) ($MN)
  • Table 46 Global Wearable Healthcare Devices Market Outlook, By Sports & Fitness Monitoring (2023-2034) ($MN)
  • Table 47 Global Wearable Healthcare Devices Market Outlook, By Rehabilitation & Recovery (2023-2034) ($MN)
  • Table 48 Global Wearable Healthcare Devices Market Outlook, By Elderly Care Monitoring (2023-2034) ($MN)
  • Table 49 Global Wearable Healthcare Devices Market Outlook, By End User (2023-2034) ($MN)
  • Table 50 Global Wearable Healthcare Devices Market Outlook, By Individual Consumers (2023-2034) ($MN)
  • Table 51 Global Wearable Healthcare Devices Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 52 Global Wearable Healthcare Devices Market Outlook, By Ambulatory Care Centers (2023-2034) ($MN)
  • Table 53 Global Wearable Healthcare Devices Market Outlook, By Homecare Settings (2023-2034) ($MN)
  • Table 54 Global Wearable Healthcare Devices Market Outlook, By Sports & Fitness Centers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.